These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31775521)

  • 1. The Effect of Human Umbilical Cord Mesenchymal Stromal Cells in Protection of Dopaminergic Neurons from Apoptosis by Reducing Oxidative Stress in the Early Stage of a 6-OHDA-Induced Parkinson's Disease Model.
    Chi H; Guan Y; Li F; Chen Z
    Cell Transplant; 2019 Dec; 28(1_suppl):87S-99S. PubMed ID: 31775521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine-induced apoptosis: Potential therapeutic strategy in Parkinson's disease.
    Bonilla-Porras AR; Arevalo-Arbelaez A; Alzate-Restrepo JF; Velez-Pardo C; Jimenez-Del-Rio M
    Cytotherapy; 2018 Jan; 20(1):45-61. PubMed ID: 29079356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Parkinson's disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF.
    Wang CC; Hu XM; Long YF; Huang HR; He Y; Xu ZR; Qi ZQ
    Life Sci; 2024 Nov; 356():123014. PubMed ID: 39182566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.
    Yan M; Sun M; Zhou Y; Wang W; He Z; Tang D; Lu S; Wang X; Li S; Wang W; Li H
    PLoS One; 2013; 8(5):e64000. PubMed ID: 23724014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells with Granulocyte Colony-Stimulating Factor Reduce Stress Oxidative Factors in Parkinson's Disease.
    Ghahari L; Safari M; Rahimi Jaberi K; Jafari B; Safari K; Madadian M
    Iran Biomed J; 2020 Mar; 24(2):89-98. PubMed ID: 31677610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis.
    Lian C; Huang Q; Zhong X; He Z; Liu B; Zeng H; Xu N; Yang Z; Liao C; Fu Z; Guo H
    FASEB J; 2021 Jul; 35(7):e21748. PubMed ID: 34152016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease.
    Chung TH; Hsu SC; Wu SH; Hsiao JK; Lin CP; Yao M; Huang DM
    Nanoscale; 2018 Feb; 10(6):2998-3007. PubMed ID: 29372743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson's disease.
    Li Y; Li Z; Gu J; Xu X; Chen H; Gui Y
    Neurosci Lett; 2022 Feb; 771():136414. PubMed ID: 34954117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of uninduced and neuronally-induced human dental pulp stromal cells in a 6-OHDA model of Parkinson's disease.
    Azevedo EM; Fracaro L; Hochuli AHD; Ilkiw J; Bail EL; Lisboa MO; Rodrigues LS; Barchiki F; Correa A; Capriglione LGA; Brofman PRS; Lima MMS
    Cytotherapy; 2024 Sep; 26(9):1052-1061. PubMed ID: 38739074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell Exosomes Alleviates Parkinson's Disease.
    Huang W; Zhang T; Li X; Gong L; Zhang Y; Luan C; Shan Q; Gu X; Zhao L
    Neuroscience; 2024 Jun; 549():1-12. PubMed ID: 38705349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease.
    Kang EJ; Lee YH; Kim MJ; Lee YM; Kumar BM; Jeon BG; Ock SA; Kim HJ; Rho GJ
    J Tissue Eng Regen Med; 2013 Mar; 7(3):169-82. PubMed ID: 22081626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model.
    Rodriguez-Pallares J; Garcia-Garrote M; Parga JA; Labandeira-Garcia JL
    J Cell Mol Med; 2021 Oct; 25(20):9884-9889. PubMed ID: 34535974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells.
    Wang N; Ji X; Wu Y; Zhou S; Peng H; Wang J; Yu S; Zhang J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCĪ“ in cell culture and animal models of Parkinson's disease.
    Latchoumycandane C; Anantharam V; Jin H; Kanthasamy A; Kanthasamy A
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):314-23. PubMed ID: 21846476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells.
    Yang S; Sun HM; Yan JH; Xue H; Wu B; Dong F; Li WS; Ji FQ; Zhou DS
    J Neurosci Res; 2013 Jul; 91(7):978-86. PubMed ID: 23633297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's disease.
    Alexanian AR; Sorokin A; Duersteler M
    J Neurol Sci; 2024 Oct; 465():123188. PubMed ID: 39178824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model.
    Shetty P; Thakur AM; Viswanathan C
    Cell Biol Int; 2013 Feb; 37(2):167-80. PubMed ID: 23339105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic-primed fetal liver mesenchymal stromal-like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice.
    Kumar A; Dudhal S; Sundari T A; Sunkara M; Usman H; Varshney A; Mukhopadhyay A
    Cytotherapy; 2016 Mar; 18(3):307-19. PubMed ID: 26857226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.